Use of Cellular-Enabled Glucometer for Diabetes Management in High-Risk Pregnancy

BackgroundType 1 and type 2 diabetes during pregnancy requires intensive glucose monitoring to ensure optimal health outcomes for mothers and infants. Standard practice includes patients monitoring their glucose four to six times a day using a standard glucometer and paper diary. Remote patient moni...

Full description

Saved in:
Bibliographic Details
Published in:Telemedicine reports 2023-10, Vol.4 (1), p.307-316
Main Authors: Jones, Rebecca D., Peng, Cheng, Odom, Lettie, Moody, Heather, Eswaran, Hari
Format: Article
Language:English
Subjects:
cellular-enabled remote patient monitoring device
diabetes management
Original Research
pregnancy
remote patient monitoring
type 1 diabetes
type 2 diabetes
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundType 1 and type 2 diabetes during pregnancy requires intensive glucose monitoring to ensure optimal health outcomes for mothers and infants. Standard practice includes patients monitoring their glucose four to six times a day using a standard glucometer and paper diary. Remote patient monitoring (RPM) offers an alternative method for diabetes management. This study aimed at measuring the patient's satisfaction with and feasibility of using a cellular-enabled RPM device for glucose management in pregnancies complicated by type 1 or type 2 diabetes.MethodsIn a mixed-methods pilot study, 59 pregnant women with type 1 or type 2 diabetes were given a cellular-enabled iGlucose glucometer. Participants completed a pre-survey, used the device for 30 days, and then completed a post-survey and semi-structured interview.ResultsParticipants were divided into two groups based on duration of device use: high-use >50 days and low-use ≤50 days. A significant difference (p 
ISSN:2692-4366
2692-4366
DOI:10.1089/tmr.2023.0033